Selected Characteristics of Patients Receiving Buprenorphine-Naloxone Treatment at 2 Primary Care Sites (n = 99)
| Characteristics | Value |
|---|---|
| Female, % | 36 |
| Mean age, years | 33 |
| Non-Hispanic white, % | 94 |
| Seropositive for hepatitis C, % | 25 |
| Average time in treatment, days | 105 |
| Privately insured, % | 27 |
| Mean stabilization dose of buprenorphine, mg | 15 |